PHARMACOLOGY EXAM 1 - (75 QUESTIONS) UP-
TO-DATE ACTUAL EXAM QUESTIONS AND 100%
ACCURATE SOLUTIONS | VERIFIED ANSWERS -
INSTANT PDF DOWNLOAD
Candidate Name: ____________________________________________
Candidate ID: ________________________________________________
Date: ___________________________
Examination Centre: _________________________________________
Time Allowed: 90 Minutes
Total Questions: 75 (This booklet contains Questions 1–30)
Instructions to Candidates:
• Read each question carefully before selecting your answer.
• Choose the one best answer for each question.
• Do not spend too much time on any one question.
• Ensure all answers are marked clearly.
• No external materials are permitted unless authorized.
• This assessment evaluates your understanding of pharmacological
principles, drug classifications, mechanisms, and safe medication practices.
Core Competency Areas Assessed:
• Pharmacokinetics and pharmacodynamics
• Drug classifications and mechanisms of action
• Medication safety and administration
• Adverse drug reactions and interactions
• Dosage calculations and clinical application
• Nursing implications in pharmacotherapy
This examination is designed to assess foundational knowledge in
pharmacology for nursing students. It focuses on applying theoretical
, concepts to clinical scenarios, ensuring safe and effective medication
administration. Candidates are expected to demonstrate critical thinking,
understanding of drug actions, and patient-centered care principles.
Disclaimer: This is an original simulation exam created for educational
purposes and is not affiliated with or derived from any official examination
body.
Q1. A patient with impaired liver function is prescribed a medication
extensively metabolized hepatically. Which pharmacokinetic change is most
likely?
A. Increased renal clearance
B. Decreased bioavailability
C. Increased half-life of the drug
D. Reduced volume of distribution
Correct Answer: C. Increased half-life of the drug
Explanation: 🟡 Hepatic impairment reduces drug metabolism, leading to
accumulation and prolonged half-life. A is incorrect because renal clearance is
unrelated. B is incorrect since bioavailability often increases. D is incorrect as
volume of distribution is not directly affected.
Q2. A nurse administers a drug with a narrow therapeutic index. Which action
is most important?
A. Administer with food
B. Monitor serum drug levels
C. Encourage fluid intake
D. Check blood pressure
,Correct Answer: B. Monitor serum drug levels
Explanation: 🟡 Narrow therapeutic index drugs require close monitoring to
avoid toxicity. A and C are general interventions. D may be relevant for some
drugs but not universally critical.
Q3. A drug binds extensively to plasma proteins. What is the clinical
implication?
A. Increased excretion
B. Decreased drug activity
C. Prolonged drug action
D. Immediate metabolism
Correct Answer: C. Prolonged drug action
Explanation: 🟡 Protein-bound drugs are released slowly, prolonging effect. A
is incorrect as binding reduces filtration. B is incorrect because bound drug is
inactive but serves as reservoir. D is incorrect.
Q4. A patient develops tolerance to a medication. What does this indicate?
A. Increased sensitivity
B. Reduced response requiring higher doses
C. Allergic reaction
D. Drug toxicity
Correct Answer: B. Reduced response requiring higher doses
Explanation: 🟡 Tolerance means diminished effect over time. A is opposite. C
and D are unrelated.
, Q5. Which route of administration bypasses first-pass metabolism?
A. Oral
B. Sublingual
C. Rectal
D. Gastric tube
Correct Answer: B. Sublingual
Explanation: 🟡 Sublingual absorption enters systemic circulation directly. A
and D undergo first-pass. C partially bypasses but not completely.
Q6. A drug antagonist works by:
A. Enhancing receptor activation
B. Blocking receptor sites
C. Increasing drug absorption
D. Stimulating enzyme activity
Correct Answer: B. Blocking receptor sites
Explanation: 🟡 Antagonists prevent receptor activation. A is agonist action. C
and D are unrelated.
Q7. A patient taking multiple medications is at risk for drug interactions
primarily due to:
A. Increased compliance
B. Polypharmacy